Definitive Contract 75D30121C12036
Award Date
9/15/21
Potential Completion Date
8/11/22
Potential Value
$5.6M
Federal Agency
CDC Pittsburgh
Awardee
Xprestest Inc.
Ultimate Awardee
Not listed
NAICS Category
561110 - Office Administrative Services
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10001, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention (CDC) awarded a $76,575,638.04 firm-fixed-price contract to Ginkgo Bioworks, Inc., a Boston-based biotechnology company, to conduct genomic testing and surveillance of SARS-CoV-2 at five major U.S. international airports. The contract, which runs through March 21, 2025, requires Ginkgo Bioworks to collect a minimum of 483,000 biological samples per year from international travelers and perform on-site reverse transcription polymerase chain...
This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Ami Expeditionary Healthcare, LLC, a healthcare support organization. The contract is for the provision of a Commercial COVID-19 Emergency Response Team and has a ceiling value of $9,996.48. The contract is a time and materials type, with an ultimate completion date of October 21, 2021. This award is part of a larger $25 million indefinite delivery vehicle the CDC has in place with Ami...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $85,741,227.24 Firm Fixed Price Definitive Contract to Ginkgo Bioworks, Inc., a biotechnology company in Boston, Massachusetts, for a Traveler-Based Genomic Surveillance Program. The contract has an ultimate completion date of March 21, 2028 and was not set aside for a specific business category. This contract appears to build on Ginkgo Bioworks' previous work with the CDC on COVID-19 genomic testing and surveillance at major...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract to XCR Diagnostics, Inc., a manufacturer of goods focused on molecular diagnostics testing. The $147,000.00 contract is for the delivery of CBOT singleplex assays, laboratory supplies, and reagents to support the CDC's diagnostic testing capabilities in Pittsburgh, Pennsylvania and Atlanta, Georgia. The contract has a completion date of August 1, 2019...
This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Ami Expeditionary Healthcare, LLC, a for-profit limited liability company. The order, valued at $727,717.40, is for a Commercial COVID-19 Emergency Response Team and is a Time and Materials contract with no set-aside designation. The order is part of a larger indefinite delivery vehicle (IDV) contract between the CDC and Ami Expeditionary Healthcare, worth up to $25 million, to provide quick-turnaround...
The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) awarded a $174,160.00 firm fixed price purchase order to XCR Diagnostics, Inc., a manufacturer of molecular diagnostic testing products, for the provision of CBOT singleplex assays and related laboratory supplies. This contract does not have a set-aside designation. XCR Diagnostics, Inc. is a subsidiary of Fluoresentric, Inc., another manufacturer of goods. The contract, awarded out of the CDC's...
This is a $1,205,149.24 Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) to Ginkgo Bioworks, Inc., a biotechnology company based in Boston, Massachusetts. The contract, titled "TRAVELER-BASED GENOMIC SURVEILLANCE," is for the provision of biotechnology services to support the CDC's public health monitoring and emergency response initiatives. The contract has an ultimate completion date of September 19, 2024 and was awarded on August 26, 2024....
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Fluoresentric, Inc., a manufacturer of goods registered to receive federal government awards. The contract, valued at $207,900.00, is for the provision of CBOT singleplex assays, which are laboratory reagents and diagnostic testing materials that support the CDC's mission of disease control and prevention. The contract has a firm fixed price pricing type and a performance period ending on August 7,...
This federal contract award to Eagle Global Scientific LLC is a $2,235,934.74 delivery order issued by the Centers for Disease Control and Prevention (CDC), a civilian agency within the Department of Health and Human Services (HHS). The contract is for professional and technical services to support the CDC's disease monitoring and prevention programs, particularly related to respiratory illnesses, healthcare-associated infections, and the COVID-19 response. The contract is a time and materials...
XCR Diagnostics, Inc., a subsidiary of Fluoresentric, Inc., has been awarded a purchase order contract valued at two hundred eleven thousand seven hundred seventy-one dollars by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract is for the delivery of a singleplex CBOT A assay to CDC's facility in Atlanta, Georgia. The firm fixed price contract runs from September 12, 2023 through October 30, 2023. No set aside designation or subcontractors...